Peter Bartenstein
Department of Nuclear Medicine
University hospital of Munich
Peter Bartenstein has not added Biography.
If you are Peter Bartenstein and would like to personalize this page please email our Author Liaison for assistance.
Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice.
European thyroid journal Sep, 2015 | Pubmed ID: 26601076
Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.
Molecular therapy : the journal of the American Society of Gene Therapy 08, 2016 | Pubmed ID: 27157666
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.
Frontiers in neuroscience , 2016 | Pubmed ID: 27378835
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Oncotarget Aug, 2016 | Pubmed ID: 27458162
Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Thyroid : official journal of the American Thyroid Association 12, 2017 | Pubmed ID: 29032724
EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.
Oncotarget Nov, 2017 | Pubmed ID: 29190908
Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model.
Neurobiology of disease 10, 2018 | Pubmed ID: 29933054
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Apr, 2019 | Pubmed ID: 30262517
Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model.
Epilepsia 12, 2018 | Pubmed ID: 30370531
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.
Pharmaceuticals (Basel, Switzerland) Jan, 2019 | Pubmed ID: 30609832
Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.
Gene therapy 04, 2019 | Pubmed ID: 30683895
Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
Cells 01, 2019 | Pubmed ID: 30696113
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Dec, 2019 | Pubmed ID: 31302633
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease.
NeuroImage. Clinical , 2019 | Pubmed ID: 31398553
Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Thyroid : official journal of the American Thyroid Association Dec, 2019 | Pubmed ID: 31816265
Metabolic correlates of dopaminergic loss in dementia with lewy bodies.
Movement disorders : official journal of the Movement Disorder Society Dec, 2019 | Pubmed ID: 31840326
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography
David Connolly*,1,
Justin J. Bailey*,1,
Harun Ilhan2,3,
Peter Bartenstein2,3,
Carmen Wängler4,
Björn Wängler5,
Melinda Wuest1,
Frank Wuest1,
Ralf Schirrmacher1
1Department of Oncology, University of Alberta,
2Department of Nuclear Medicine, University Hospital of Munich,
3ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, LMU Munich,
4Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University,
5Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved